Quality in rare disease therapy management
Date posted: May 26, 2021
The Accreditation Commission for Health Care (ACHC) awarded Optum® Frontier Therapies full accreditation with Distinction in Rare Diseases and Orphan Drugs.
Optum Frontier Therapies pharmacies located in Las Vegas, Nevada and Flint, Michigan comprise two of only four specialty pharmacies to earn the organization’s distinction for providing access to orphan status drugs that treat rare diseases.
Expert rare disease drug management
Advanced therapeutics require precise handling and holistic patient support, along with detailed monitoring and reporting. By earning this distinction, Optum Frontier Therapies has demonstrated our commitment to meeting the commission’s regulatory requirements and standards that facilitate a higher level of performance and patient care for rare disease.
The select ACHC Distinction in Rare Diseases and Orphan Drugs spells out processes and procedures pharmacies must have in place in specific areas when dispensing these therapies, including:
- Patient connection to patient advocacy and financial-assistance organizations
- Specialized training of patients and pharmacy staff
- Manufacturer collaboration
- Supply-chain logistics and disaster preparation to ensure continuity of drug delivery
- Risk, Evaluation, and Mitigation Strategies (REMS) and adverse-event reporting
- Analysis of patient outcomes
